Atlantic Union Bankshares Corp Purchases 3,676 Shares of Intuitive Surgical, Inc. $ISRG

Atlantic Union Bankshares Corp raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,759 shares of the medical equipment provider’s stock after acquiring an additional 3,676 shares during the period. Atlantic Union Bankshares Corp’s holdings in Intuitive Surgical were worth $10,179,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Tobam raised its stake in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares during the last quarter. Kilter Group LLC acquired a new position in shares of Intuitive Surgical during the second quarter valued at about $27,000. Princeton Global Asset Management LLC purchased a new position in shares of Intuitive Surgical in the 2nd quarter valued at approximately $30,000. Greykasell Wealth Strategies Inc. acquired a new stake in Intuitive Surgical in the 3rd quarter worth approximately $27,000. Finally, Riggs Asset Managment Co. Inc. grew its position in Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after purchasing an additional 32 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ISRG. HSBC raised their price target on shares of Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a report on Monday, January 26th. The Goldman Sachs Group restated a “buy” rating and issued a $714.00 target price on shares of Intuitive Surgical in a research note on Friday, January 9th. Daiwa Capital Markets boosted their price target on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Royal Bank Of Canada raised their price objective on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Finally, Raymond James Financial lifted their target price on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $620.41.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 3,500 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $575.00, for a total value of $2,012,500.00. Following the sale, the executive vice president directly owned 5,758 shares of the company’s stock, valued at approximately $3,310,850. This trade represents a 37.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 4,500 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00. Following the transaction, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $496,455.52. The trade was a 83.23% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 75,683 shares of company stock valued at $42,066,425 in the last ninety days. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

ISRG opened at $504.22 on Monday. The firm has a fifty day moving average price of $558.64 and a 200 day moving average price of $511.62. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $609.08. The stock has a market cap of $180.75 billion, a P/E ratio of 63.91, a P/E/G ratio of 3.90 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the previous year, the company earned $2.21 earnings per share. The firm’s revenue for the quarter was up 18.8% on a year-over-year basis. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.